- Home
- LIN vs MRK Comparison
LIN vs MRK Comparison
Compare LIN & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LIN | MRK |
|---|---|---|
| Founded | 1879 | 2000 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 224.6B | 268.7B |
| IPO Year | 2017 | 1994 |
Fundamental Metrics
Financial Performance| Metric | LIN | MRK |
|---|---|---|
| Price | $485.41 | $113.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 14 |
| Target Price | ★ $518.00 | $124.29 |
| AVG Volume (30 Days) | 2.2M | ★ 7.2M |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | 1.23% | ★ 2.98% |
| EPS Growth | 7.27 | ★ 8.01 |
| EPS | ★ 14.61 | 7.28 |
| Revenue | $33,986,000,000.00 | ★ $65,011,000,000.00 |
| Revenue This Year | $5.69 | $3.74 |
| Revenue Next Year | $5.03 | $5.47 |
| P/E Ratio | $33.53 | ★ $15.70 |
| Revenue Growth | ★ 2.97 | 1.31 |
| 52 Week Low | $387.78 | $75.40 |
| 52 Week High | $510.32 | $125.14 |
Technical Indicators
Market Signals| Indicator | LIN | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 52.30 | 40.17 |
| Support Level | $459.69 | $105.23 |
| Resistance Level | $510.32 | $125.14 |
| Average True Range (ATR) | 8.60 | 2.48 |
| MACD | -2.10 | -0.82 |
| Stochastic Oscillator | 47.39 | 11.52 |
Price Performance
Historical ComparisonAbout LIN Linde plc
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $34 billion in revenue in 2025.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).